Icon

ADHANSIA XR (nda212038)- (25MG,35MG,45MG,55MG,70MG,85MG)

METHYLPHENIDATE HYDROCHLORIDE PURDUE PHARMA LP
25MG,35MG,45MG,55MG,70MG,85MG
No Yes
2038-Nov-19 Expired
None 2022-Feb-27
None No
ADHANSIA XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
25MG ** ** - - -
35MG ** ** - - -
45MG ** ** - - -
55MG ** ** - - -
70MG ** ** - - -
85MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.